Seer (NASDAQ:SEER) Shares Down 2.6% – Here’s What Happened

Seer, Inc. (NASDAQ:SEER)’s share price dropped 2.6% during mid-day trading on Friday . The stock traded as low as $1.68 and last traded at $1.68. Approximately 263,201 shares were traded during mid-day trading, a decline of 30% from the average daily volume of 375,799 shares. The stock had previously closed at $1.7250.

Analyst Ratings Changes

SEER has been the topic of a number of recent analyst reports. Wall Street Zen raised shares of Seer to a “hold” rating in a research report on Saturday, December 13th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Seer in a report on Thursday, January 22nd. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has an average rating of “Sell”.

Seer Stock Down 2.6%

The firm has a market capitalization of $93.73 million, a price-to-earnings ratio of -1.31 and a beta of 1.66. The company has a fifty day moving average price of $1.87 and a two-hundred day moving average price of $1.98.

Seer (NASDAQ:SEER) last announced its earnings results on Thursday, February 26th. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.32) by $0.03. The business had revenue of $4.20 million for the quarter, compared to analysts’ expectations of $4.60 million. Seer had a negative net margin of 443.96% and a negative return on equity of 26.04%. On average, equities analysts anticipate that Seer, Inc. will post -1.42 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Seer

A number of institutional investors and hedge funds have recently made changes to their positions in SEER. Corient Private Wealth LLC purchased a new stake in shares of Seer during the fourth quarter worth approximately $116,000. Quadrature Capital Ltd purchased a new position in Seer in the 4th quarter valued at $101,000. Barclays PLC increased its stake in Seer by 685.0% in the 4th quarter. Barclays PLC now owns 60,717 shares of the company’s stock valued at $111,000 after buying an additional 52,982 shares during the period. Marshall Wace LLP acquired a new position in Seer in the 4th quarter valued at $85,000. Finally, Dimensional Fund Advisors LP raised its position in Seer by 2.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 235,485 shares of the company’s stock worth $431,000 after buying an additional 6,304 shares during the last quarter. 75.20% of the stock is owned by hedge funds and other institutional investors.

Seer Company Profile

Seer, Inc is a life sciences company focused on pioneering next-generation proteomics, the large-scale study of proteins and their functions in complex biological systems. By leveraging proprietary nanoparticle-based technology, Seer’s platform enables high-throughput, unbiased protein analysis from biological samples, addressing a critical bottleneck in drug discovery, biomarker research and precision medicine.

The company’s flagship Proteograph Product Suite combines engineered nanoparticle assays with advanced mass spectrometry and bioinformatics pipelines to deliver deep proteomic coverage in a scalable workflow.